MDS to AML, treatment and options with Dr. Tiffany Tanaka, UC San Diego | Aplastic Anemia & MDS International Foundation

MDS to AML, treatment and options with Dr. Tiffany Tanaka, UC San Diego

Dr. Tiffany Tanaka from the University of California, San Diego explains the development of High-Risk MDS into AML. She talks about new diagnostic and treatment regimens for these patients.